Evidence map›Paper›PMID 22020219›Full record

ArticleFEBS letters2011

Mechanism of KATP hyperactivity and sulfonylurea tolerance due to a diabetogenic mutation in L0 helix of sulfonylurea receptor 1 (ABCC8).

Andrey P Babenko, Martine Vaxillaire

Abstract read
In one paragraph

Article in FEBS letters, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. New insights into KNature reviews. Endocrinology · 2020
    Review
  3. Article
  4. Article
  5. Neonatal Diabetes and the KTrends in endocrinology and metabolism: TEM · 2017
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Andrey P BabenkoPacific Northwest Research Institute, University of Washington Diabetes Endocrinology Research Center, Seattle, WA 98122, United States. ababenko@pnri.org
Martine Vaxillaire

Funding

ABCC8/KCNJ11 Mechanisms and DiabetesR01DK077827 · NIDDK · PACIFIC NORTHWEST RESEARCH INSTITUTE · PI BABENKO, ANDREY P · 2009 to 2010
$813k
NIDDK NIH HHS DK077827NIDDK NIH HHS R01 DK077827
6 · The paper itself

Abstract

Activating mutations in different domains of the ABCC8 gene-coded sulfonylurea receptor 1 (SUR1) cause neonatal diabetes. Here we show that a diabetogenic mutation in an unexplored helix preceding the ABC core of SUR1 dramatically increases open probability of (SUR1/Kir6.2)(4) channel (KATP) by reciprocally changing rates of its transitions to and from the long-lived, inhibitory ligand-stabilized closed state. This kinetic mechanism attenuates ATP and sulfonylurea inhibition, but not Mg-nucleotide stimulation, of SUR1/Kir6.2. The results suggest a key role for L0 helix in KATP gating and together with previous findings from mutant KATP clarify why many patients with neonatal diabetes require high doses of sulfonylureas.

Indexed as

MutationAnimalsATP-Binding Cassette TransportersCricetinaeDiabetes MellitusHumansIon Channel GatingKATP ChannelsKcnj11 ChannelKineticsLigandsModels, MolecularPotassium Channels, Inwardly RectifyingProtein ConformationReceptors, DrugSulfonylurea CompoundsABCC8 protein, humanATP-Binding Cassette TransportersKATP ChannelsKcnj11 ChannelLigandsPotassium Channels, Inwardly RectifyingReceptors, DrugSulfonylurea CompoundsSulfonylurea Receptors

Identifiers

PMID22020219
PMCPMC3215797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.